Difficulty: Medium
Average Score: 65%
Practice
A 49-year-old man with advanced squamous cell carcinoma of the skin is treated with topical 5-fluorouracil. He presents to his oncologist for follow-up. In addition to monitoring renal and hepatic function for toxicity, one could theoretically measure levels of which of the following excreted products?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Fluoroalanine. When a patient is treated with 5-fluorouracil, it is metabolized into various compounds, including fluoroalanine. Fluoroalanine is a toxic metabolite that can be excreted by the body. Monitoring levels of fluoroalanine can provide insights into the metabolism and clearance of 5-fluorouracil, helping to assess its efficacy and potential toxicity.
Option A) Alanine is a common amino acid and not directly related to the metabolism of 5-fluorouracil. Option B) Creatinine is a byproduct of muscle metabolism and mainly used to assess renal function, not specific to 5-fluorouracil treatment. Option D) Glucose is a simple sugar and not a metabolite associated with 5-fluorouracil.
In an educational context, understanding the metabolic pathways of chemotherapy drugs like 5-fluorouracil is crucial for healthcare providers to monitor treatment efficacy and potential side effects accurately. By knowing which excreted products to measure, clinicians can tailor patient care and adjust treatment plans accordingly, improving patient outcomes and safety.
Option A) Alanine is a common amino acid and not directly related to the metabolism of 5-fluorouracil. Option B) Creatinine is a byproduct of muscle metabolism and mainly used to assess renal function, not specific to 5-fluorouracil treatment. Option D) Glucose is a simple sugar and not a metabolite associated with 5-fluorouracil.
In an educational context, understanding the metabolic pathways of chemotherapy drugs like 5-fluorouracil is crucial for healthcare providers to monitor treatment efficacy and potential side effects accurately. By knowing which excreted products to measure, clinicians can tailor patient care and adjust treatment plans accordingly, improving patient outcomes and safety.